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Although previous bacterial typing methods have 
been informative about potential relatedness of iso-
lates collected during outbreaks, next-generation 
sequencing has emerged as a powerful tool to not 
only look at similarity between isolates, but also put 
differences into biological context. In this study, we 
have investigated the whole genome sequence of five 
Pseudomonas aeruginosa isolates collected during a 
persistent six-year outbreak at Nottingham University 
Hospitals National Health Service (NHS) Trust – City 
Campus, United Kingdom. Sequencing, using both 
Roche 454 and Illumina, reveals that most of these iso-
lates are closely related. Some regions of difference 
are noted between this cluster of isolates and previ-
ously published genome sequences. These include 
regions containing prophages and prophage remnants 
such as the serotype-converting bacteriophage D3 and 
the cytotoxin-converting phage phi CTX. Additionally, 
single nucleotide polymorphisms (SNPs) between the 
genomic sequence data reveal key single base differ-
ences that have accumulated during the course of this 
outbreak, giving insight into the evolution of the out-
break strain. Differentiating SNPs were found within a 
wide variety of genes, including lasR, nrdG, tadZ, and 
algB. These have been generated at a rate estimated 
to be one SNP every four to five months. In conclusion, 
we demonstrate that the single base resolution of 
whole genome sequencing is a powerful tool in analy-
sis of outbreak isolates that can not only show strain 
similarity, but also evolution over time and potential 
adaptation through gene sequence changes.
Introduction
Pseudomonas aeruginosa is a Gram-negative bac-
terium that is widespread in the environment and 
engages in a wide variety of interactions with eukar-
yotic host organisms. It is a common opportunistic 
pathogen in humans, causing a broad range of infec-
tions in community and healthcare settings. The most 
serious manifestations of infection include bacterae-
mia (particularly in neutropenic patients), pneumonia 
(particularly in cystic fibrosis patients and critically ill 
patients), urinary tract infections and wound infections 
(especially in patients with burn injuries) [1,2]. This 
organism is intrinsically resistant to many antibiotics 
and in recent years resistance has emerged to what 
were previously antimicrobial agents of choice [3,4]. 
As P. aeruginosa is ubiquitous in the environment and 
also forms part of the resident microbiota of many 
patients, molecular typing methods are required to 
identify the sources and routes of transmission within 
the healthcare setting. Current molecular epidemio-
logical typing systems, such as pulsed-field gel elec-
trophoresis (PFGE) and variable-number tandem repeat 
(VNTR) analyses, have provided evidence of clonal out-
breaks of P. aeruginosa affecting clinics or hospitals 
across the United Kingdom (UK) [5,6]. For example, 
such approaches have identified several clones (the 
Liverpool, Midlands 1 and Manchester strains) affect-
ing multiple cystic fibrosis patients in the UK [5-7]. 
However, these typing methods are of limited resolu-
tion when compared to whole genome sequencing. In 
addition, traditional typing methods fail to provide any 
insights into the biology of outbreak strains, or show 
how they might be evolving over time. 
A prolonged P. aeruginosa outbreak at Nottingham 
University Hospitals National Health Service (NHS) 
Trust - City Campus (UH-NHST-CC) that lasted from 
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2001 to 2007 illustrates some of these issues [8]. 
Although the outbreak has been brought under control, 
one to two cases are still seen each year, so it has not 
been completely eliminated. Here, we have seen a pat-
tern of apparently endemic infection, associated with 
a single clonal lineage, which was isolated from over 
40 patients and also from the hospital environment, as 
evidenced in previous studies of the isolates [8] and 
ongoing active surveillance and molecular typing. 
The outbreak was first detected when infections 
caused by five multi-resistant isolates were noted on 
an 18-bed bone marrow transplant unit at UH-NHST-CC 
in April 2001. These isolates were resistant to cef-
tazidime (CTZ), ciprofloxacin (CIP), gentamicin (GEN), 
piperacillin-tazobactam (TZP), and the carbapenems, 
but susceptible to amikacin (AMK) and colistin (COL). 
Surveillance was enhanced, laboratory records were 
reviewed to identify other cases, and environmental 
sampling was undertaken. Over the next two years, 
further isolates from the critical care unit and a new 
bone marrow transplant unit at the same hospital were 
identified, initially on the basis of the same antibio-
gram. As a result of the infection control programmes 
initiated in response to these outbreaks, infections 
were identified in 32 haematology patients [8]. Some 
patients acquired the multi-resistant P. aeruginosa 
without temporal overlap with other positive patients, 
suggesting an environmental source. Infection control 
investigations at the time suggested that the outbreak 
was associated with colonisation of hand washing 
basins. 
Initial molecular epidemiological typing was performed 
by PFGE using restriction enzyme SpeI [9,10] and iden-
tified a single outbreak strain among clinical and envi-
ronmental isolates [8]. Similarity between all isolates 
was >85% and these formed a single group in cluster 
analysis, defined as the Nottingham/Trent cluster. In 
addition, the recommendations of Tenover et al. [10] 
were followed, which stipulate that isolates belonging 
to the same strain should differ by a maximum of four 
fragments. Isolates were additionally typed by random 
amplification of polymorphic DNA (RAPD) [11] and all 
demonstrated the same pattern [8]. It was found that 
in critical care, tracheostomy was the strongest risk 
factor for acquisition and that the tracheostomy inner 
tubes were being cleaned in hand wash basins that 
were found to be contaminated. The correct fitting of 
waste trap heaters, the removal of one persistently 
colonised sink, enhanced surveillance, and a review of 
equipment and sink cleaning, particularly in the case of 
tracheostomy equipment helped to bring the outbreak 
under control. In clinical haematology, oral colistin was 
introduced for selective decontamination of the gut 
during neutropenia and use of ciprofloxacin, to which 
the strain is resistant, was reduced for neutropenic 
prophylaxis.
Whole genome sequencing, facilitated by the advent 
of high-throughput approaches, brings the promise 
of single-base-pair resolution between isolates, mak-
ing it the ultimate molecular typing method for bacte-
ria. Several recent studies have shown that analysis of 
single nucleotide polymorphisms (SNPs) in bacterial 
genomes provides a means of determining relatedness 
between epidemiologically linked isolates and track-
ing bacterial evolution over periods of months to years 
[12-16]. In particular, several studies have tracked the 
genetic changes that emerge during long-term coloni-
sation of cystic fibrosis patients [17,18]. In addition, 
genome sequencing provides a strain-specific list of 
protein-coding genes, which, through comparisons 
with the genes sets of other strains from the same spe-
cies can provide insights into the unique biology of an 
epidemic strain. We therefore applied high-throughput 
sequencing to five isolates from the UH-NHST-CC hos-
pital outbreak to determine whether genome sequenc-
ing can inform our understanding of the epidemiology 
and biology of a hospital pathogen in this setting.
Methods
Microbiology
Isolates of P. aeruginosa were collected from the 
microbiological specimens of patients cared for at 
the Queen’s University Medical Centre over a six-year 
period from January, 2002 to December, 2007. Isolates 
were frozen on beads and stored at -80°C. P. aeruginosa 
isolates were sent to the Health Protection England’s 
(HPE) Laboratory of HealthCare Associated Infection 
in London for analysis by PFGE. Four isolates from dif-
ferent time points in the outbreak were selected for 
genome sequencing in this study on the basis of PFGE 
and RAPD results, as well as an additional isolate from 
June 2001 (Table 1). This additional isolate was identi-
fied as part of the look-back exercise initiated after the 
first outbreak; its PFGE profile was established by the 
HPE. The antimicrobial susceptibilities of isolates were 
tested using the disk diffusion method against AMK, 
aztreonam (AZT), CTZ, COL, CIP, GEN, meropenem 
(MER), tobramycin (TOB) and TZP and according to 
Table 1
Selection for sequencing of Pseudomonas aeruginosa 
isolates originating from an outbreak in Nottingham that 
occurred between 2001 and 2007, United Kingdom
Isolate Isolation date Specimen
Sequencing 
platform
PANOTK11 Jun 2001 Swab from line site Illumina
PANOT101 Jan 2002 Urine Illumina
PANOT106 Jan 2003 Blood 454 and Illumina
PANOT340 Apr 2005 Swab from line site Illumina
PANOT738 Dec 2007 Faeces Illumina
NHS: National Health Service.
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British Society for Antimicrobial Chemotherapy (BSAC) 
guidelines [19].
Isolation of genomic DNA and 
high-throughput sequencing 
 Genomic DNA was obtained from colony-purified P. aer-
uginosa, using the DNeasy DNA extraction kit accord-
ing to the manufacturer’s instructions (Qiagen). DNA 
from isolate PANOT106 was sequenced using whole 
genome shotgun and 2.5-kilobase paired-end 454 pro-
tocols in accordance with the manufacturer’s instruc-
tions (Roche) at the University of Liverpool’s Centre 
for Genomic Research. Isolates PANOT106, PANOTK11, 
PANOT101, PANOT340, and PANOT738 were sequenced 
one sample per lane using the Illumina GA2, running 35 
cycles with paired-end libraries (~250 base-pair insert 
size). Sequencing on the Illumina GA2 platform was 
carried out at the sequencing centre of the University 
of Washington at St. Louis.
Genome assembly
Roche 454 reads for isolate PANOT106 were assem-
bled de novo with Newbler v2.3 (Roche) to create a 
reference assembly, using the default settings with 
–g enabled to produce contig graphs for use later in 
the variant detection pipeline. Nesoni 0.51 (Victorian 
Bioinformatics Consortium) was used on the Illumina 
reads for PANOT106 to correct errors in the reference 
assembly, particularly short indels in regions with low 
depth of coverage or in homopolymeric tracts. Nesoni 
parameters were: depth 10; purity 0.8; ambiguity-
codes 1; fidelity 1.0; monogamous 1; trim 0; max-pair-
sep 250; only-pairs 1; suffix1 /1; suffix2 /2; same-dir 0; 
circular 0; savehits 0. Bowtie v0.12.0 [20] was used to 
align the PANOT106 Illumina reads to complete P. aer-
uginosa genomes available in GenBank, using param-
eters --solexa -quals -S -m 1 -p 4. The progressive 
Mauve component of Mauve (version 2.3.1) was used to 
map the PANOT106 reference assembly to the genome 
sequence of P. aeruginosa PAO1.
Illumina sequences for isolates PANOTK11, PANOT101, 
PANOT340, and PANOT738 were assembled using 
SOAPdenovo 1.03 (http://soap.genomics.org.cn/soap-
denovo.html). Assemblies were individually annotated 
using the xBASE annotation pipeline [21-26].
Creation of a well-validated single 
nucleotide polymorphism (SNP) set
A series of filters were applied to the sequence data 
to create a set of high-confidence SNP variants. Bowtie 
v0.12.0 was used to align the Illumina data for each 
of the five sequenced strains to the PANOT106 refer-
ence assembly and variants extracted using samtools 
with parameters –cv –N n to create set <VARIANTS>. 
The value of n was set to the number of isolates in the 
sample. 
Putative variants were filtered with samtools.pl varFil-
ter to create set <FILTER1>. varFilter was run with the 
following parameters: -Q 25 -d 10 -D 100 -G 25 -w 10 -W 
10 -N 2 -l 30, equating to the following filtering options: 
Minimum root mean square mapping quality for SNPs, 
25; Minimum root mean square mapping quality for 
gaps, 10; Minimum read depth, 10; Maximum read 
depth, 90; Minimum indel score for nearby SNP filter-
ing, 25; SNP within INT bp around a gap to be filtered, 
10; Window size for filtering dense SNPs, 10; Max num-
ber of SNPs in a window, 2; Window size for filtering 
adjacent gaps, 30. 
These variant calls were further filtered to a set with 
SNP quality of 30 (phred-scale) to create set <FILTER2>. 
The position of each variant call was related to the 
P. aeruginosa strain PAO1 genome sequence by refer-
ence to the Mauve alignment. Variant calls with no cor-
responding alignment in strain PAO1 were discarded, 
creating set <FILTER3>. Variant calls which occurred 
in contigs in the reference assembly which were not 
included in the scaffold assembly and thus were likely 
to be repetitive were further excluded from analysis, 
resulting in <FILTER4>. Variant calls which occurred in 
contigs which had coverage depth greater or less than 
two standard deviations from the mean were excluded, 
resulting in <FILTER5>. Finally, variant calls with a vari-
ant frequency of less than 0.9 were discarded. Variant 
frequency was determined by dividing the alignment 
depth by the number of reads supporting the variant 
call.
Analysis of gene content
Protein-coding sequences (CDSs) in the PANOT106 
assembly were identified using Gene Locator and 
Interpolated Markov ModelER (GLIMMER) [23]. Protein 
Basic Local Alignment Search Tool (BLASTP) [21] was 
used to compare the set of CDSs in PANOT106 with 
the predicted protein repertoires of other completed 
P. aeruginosa genome sequences. Regions of differ-
ence (RODs) between the PANOT106 and the known 
P. aeruginosa pan-genome (as defined by complete 
genomes in GenBank) were identified on the basis of 
the following criteria: the ROD must contain ≥ 10 strain-
specific CDSs, which have no orthologues in other 
genomes (as defined by mutual best-hit analysis), with 
the ROD interrupted by no more than five genes already 
present in the pan-genome. Orthologues were com-
puted using OrthoMCL v2.0 with default parameters 
[27]. Singletons (coding sequences which do not have 
orthologues in other outbreak isolates) were verified 
by translated nucleotide databases BLAST (TBLASTN) 
searches against the original sequence. Additional 
information with regards to the annotated features 
made use of the Pseudomonas Genome Database [28].
Results
Assembly of the genome sequence data
 Using the Roche 454 next-generation genome 
sequencing platform, 6,720,954 bases were generated 
from the DNA extracted from isolate PANOT106. Reads 
were assembled, using Newbler, into 1,059 contigs, 
which were further assembled into 19 scaffolds using 
4 www.eurosurveillance.org
paired-end sequence data to determine the relative 
positions and distances of contigs. The N50 of the scaf-
folds is 825,048 and the average paired end distance is 
2,365 bases, with a standard deviation of 591 bases.
The next-generation sequencing data generated on the 
Illumina platform for isolates PANOT106, PANOTK11, 
PANOT101, PANOT340, and PANOT738, is summarised 
in Table 2. Coverage with the 35 base Illumina reads 
ranged from 62X to 90X. The data for isolate PANOT106 
was used to correct the assembly of this genome 
sequence based on the 454 data. This resulted in 283 
total edits to the original assembled sequence.
Antibiogram differences
The only detected difference in antibiotic resistance 
amongst the five isolates was AMK resistance in 
PANOTK11 (data not shown). Resistance to aminogly-
cosides is typically associated with aminoglycoside-
modifying enzymes. Each of the outbreak strains 
carry identical aminoglycoside 3’-phosphotrans-
ferase type IIb coding sequences homologous to the 
Pseudomonas strain PAO1 CDS with accession PA4119. 
Additionally there were no SNPs detected upstream 
to suggest a change in promoter in PANOTK11. The 
alternative resistance-conferring aminoglycoside 
4’-O-adenylyltransferase IIb [29] was not found in any 
of the outbreak strains. We therefore conclude that 
AMK resistance in PANOTK11 is probably due to imper-
meability or efflux, although even if true, this fails to 
explain why resistance to other aminoglycosides was 
unaffected [30].
Novel sequences within the genomes 
of the outbreak isolates
There are six large regions of difference between 
PANOT106 and the P. aeruginosa pan-genome (Figure 
panel A-F), five of which appear to be prophages or 
prophage remnants. In particular, PANOT106 contains 
a region that resembles the serotype-converting P. aer-
uginosa bacteriophage D3 and a region that encodes 
homologues of phage structural proteins from phi CTX, 
a cytotoxin-converting phage of P. aeruginosa. The 
only non-prophage region of difference contains cop-
per- and arsenic-resistance genes and is homologous 
to a similar region in the genome of Stenotrophomonas 
sp. SKA14.
PANOTK11 has a 48 kb sequence that is not present in 
the other strains sequenced here (Figure panel G). This 
region was assembled into a single contig and was 
annotated to contain 24 CDSs. Although this region has 
no homologue in any of the other strains sequenced 
here, it is homologous to sequence data from isolate 
PACS171b [31], which was isolated from the orophar-
ynx of a nine month-old cystic fibrosis patient [32]. Of 
the 48 kb, all but 13 kb share similarity with isolate 
PACS171b; these 35 kb mostly contain hypothetical 
genes and a putative restriction-modification system 
and putative sigma-54 transcriptional regulator. Within 
the 13 kb region that is different from isolate PACS171b, 
isolate PANOTK11 contains a member of the DEAD box 
helicase family, an OLD family endonuclease, and a 
hypothetical gene.
No novel sequences were found within the genomes of 
PANOT101, PANOT340, and PANOT738, in comparison 
with the P. aeruginosa pan-genome.
Flagellum operon
All five of the outbreak strains are missing a portion 
of the flagellum operon compared to that present in 
P. aeruginosa strains PAO1 and LESB58. The corre-
sponding CDS PA1088, encoding flagellar glycosyl 
transferase FgtA is not present in the outbreak iso-
lates sequenced here. The fliC (PA1092) gene and CDSs 
PA1092–PA1096 are present, although these are diver-
gent in their nucleotide sequences.
Genome-wide single nucleotide polymorphism 
(SNP) analysis of outbreak strains
The PANOT106 sequence, assembled from Illumina 
and 454 sequence data, aligns well with the 
P. aeruginosa strains PAO1 (95.3% sequence identity), 
Table 2
Illumina sequencing results for Pseudomonas aeruginosa isolates originating from an outbreak in Nottingham that occurred 
between 2001 and 2007, United Kingdom
Isolate Total reads Reads per pair Bases Coverage Scaffolds
Maximum 
scaffold 
size
Bases in 
scaffolds
Average 
scaffold 
size
 N50 
scaffold 
size
N90 
scaffold 
size
PANOTK11 11,936,530 5,968,265 417,778,550 ~70X 393 168,419 6,857,254 11,024 41,132 9,556
PANOT101 15,007,136 7,503,568 525,249,760 ~88X 189 288,005 6,823,034 17,494 110,879 25,874
PANOT106 15,392,542 7,696,271 538,738,970 ~90X 202 414,841 6,823,529 18,196 81,409 20,375
PANOT340 10,684,280 5,342,140 373,949,800 ~62X 756 161,292 6,821,477 6,363 20,384 3,728
PANOT738 14,983,686 7,491,843 524,429,010 ~87X 294 225,595 6,818,630 14,001 51,282 12,127
NHS: National Health Service.
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LESB58 (92.5%), and PA14 (92.4%) genome sequences 
and less well with PA7 (77.8%). Comparisons of the 
Ilumina sequences from isolates PANOTK11, PANOT101, 
PANOT340, and PANOT738 with the PANOT106 assem-
bly generated a large number of variant calls. Several 
hundred variants were discarded during the filtering 
of variants to identify high-quality informative SNPs 
that vary between the outbreak isolates and which are 
associated with 37 polymorphic loci (Table 3). Twenty-
four of the SNPs result in non-synonymous changes 
to the associated encoded amino acid in the PAO1-
annotated coding region (Table 4). This high frequency 
of non-synonymous changes (24 of 37) suggests that 
some of the SNPs represent adaptive changes.
Nineteen of the SNPs separate PANOTK11 from the 
other four UH-NHST-CC Nottingham isolates (Table 3). 
None of these nineteen SNPs are found in any of the 
other four outbreak isolates, which all share greater 
similarity to the reference strain PAO1 at these SNP 
loci. These SNPs in this isolate, the 48 kb region pre-
sent only in this isolate, and the AMK resistance of 
this isolate indicate that PANOTK11, despite being 
identified as related to the other outbreak isolates 
as part of the Nottingham/Trent cluster via PFGE and 
RAPD, is not part of the same outbreak and cannot 
represent the index case. Despite the earlier typing 
results, PANOTK11 is a phylogenetic outlier when com-
pared to other outbreak isolates on the genomic level. 
Interestingly, one of these PANOTK11-specific SNPs 
(PNSNP12) maps to lasR (Table 4), encoding a tran-
scriptional regulator that responds to a homoserine 
lactone signal to activate expression of P. aeruginosa 
virulence factors through quorum sensing. Mutations 
in LasR have been reported in several contexts, includ-
ing adaptation to the airways of cystic fibrosis patients 
[33]. PNSNP12 does not appear to be within the helix-
turn-helix DNA binding domain of the encoded protein 
according to the available sequence and functional 
information in UniProt [35], and to predictions by the 
helixturnhelix (HTH) software tool [34] but SNP muta-
tions in other LasR regions, including the ligand binding 
domain, have been reported previously [36]. Another of 
the PANOTK11 SNPs (PNSNP34) maps to algB (Table 4), 
encoding an NtrC-like response regulator, which con-
trols alginate biosynthesis in mucoid P. aeruginosa 
[37]. In this case the SNP falls within the helix-turn-
helix motif predicted by HTH [34] and described pre-
viously [38]. This SNP may therefore impact upon the 
virulence of PANOTK11 and differences in alginate bio-
synthesis should be explored.
PANOT101 and PANOT106 were isolated a year apart 
(2002 and 2003, respectively) and share many of the 
same non-synonymous SNPs, apart from five identified 
here (Table 3). PNSNP10, within a sensor/response reg-
ulator hybrid (PA0928), and PNSNP25, within nrdG, in 
PANOT106 are also shared with isolates PANOT340 and 
PANOT738 (Tables 3 and 4). PNSNP11 and PNSNP13 in a 
hypothetic protein (PA0938) and two-component sen-
sor (PA1458), respectively, are only found in PANOT106 
in this study. Likewise, PNSNP26 in PANOT101 (Table 3) 
is only found within this isolate in this study. PNSNP26 
is within speC encoding ornithine decarboxylase 
(PA4519; Table 4) part of the biosynthetic pathway to 
produce putrescine, required for growth, but loss of 
function of this protein can be compensated through 
an alternative putrescine biosynthesis pathway using 
speA [39].
Figure 
Regions of sequence difference between Nottingham 
Pseudomonas aeruginosa isolates and the P. aeruginosa 
pan-genome
Arrowed blocks show annotated coding regions, indicating their 
direction of transcription. 
Panel A. A 17.2 kb prophage region containing a chromate 
resistance protein (A), chromate transporter (B), and phage 
structural proteins (C). 
Panel B. A 29.4 kb copper/arsenate resistance region containing 
a heavy metal Resistance-Nodulation-cell Division (RND) efflux 
outer membrane protein (A), a copper resistance operon (B), and 
arsenate resistance genes (C). 
Panel C. A 32.1 kb lambda-like prophage region containing a phage 
integrase (A) and alginate biosynthesis regulatory protein (B). 
Panel D. A 35.3 kb prophage region. 
Panel E. A Phi-CTX-like prophage region. 
Panel F. A 21.4 kb serine protease containing region of difference 
containing subtilisin-related serine protease (A). 
Panel G. A 47.9 kb region of difference from PANOTK11 containing a 
tellurium resistance protein (A).
A B C
A CB
BA
A
A
A
B
C
D
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G
Regions of sequence diﬀerence between isolate 
PANOT106 and the P. aeruginosa pan-genome 
Region of sequence diﬀerence between isolate 
PANOTK11 and the P. aeruginosa pan-genome 
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The two subsequent strains, PANOT340 and PANOT738, 
isolated in 2005 and 2007, respectively, show a pro-
gressive increase in the number of SNPs relative to 
PANOT106. These three isolates share two non-syn-
onymous SNPs (Table 3), one, PNSNP10, within a sen-
sor/response regulator hybrid (PA0928, gacS) and 
one, PNSNP25, in a class III (anaerobic) ribonucleo-
side-triphosphate reductase activating protein gene 
(PA1919, nrdG). Five shared non-synonymous SNPs 
(PNSNP2, PNSNP5, PNSNP19, PNSNP23, and PNSNP32) 
are present in isolates PANOT340 and PANOT738, but 
not in the other outbreak isolates. In isolate PANOT738, 
an additional eight SNPs are present, three leading to 
non-synonymous changes (Table 3) and five in inter-
genic regions. This progressive accumulation of SNPs 
is consistent with an ancestor-descendant relationship. 
The acquisition of five SNPs in two and a third years (5 
SNPs in 28 months, or 5.6 months per SNP) and a fur-
ther eight SNPs in two and two third years (8 SNPs in 
32 months, or 4 months per SNP), with 13 over a span 
of five years from January 2003 to December 2007 (13 
SNPs in 60 months, 4.6 months per SNP) suggests that 
a new SNP is acquired in this lineage on average every 
four to five months.
The five non-synonymous SNPs in common between 
isolates PANOT340 and PANOT738 include PNSNP32 
which is associated with a type II citrate synthase 
(PA1580, gltA), PNSNP2 in a hypothetical protein that 
may be a thioesterase (PA3130), PNSNP5 in a putative 
methylated-DNA--protein-cysteine methyltransferase 
(PA3596), PNSNP23 in a probable two-component 
response regulator (PA5364), and PNSNP19 in an ATP-
dependent protease peptidase subunit of heat shock 
protein HslV (PA5053, hslV ). The small form of the cit-
rate synthase protein encoded by gltA is involved in the 
Krebs cycle and is expressed in excess during station-
ary phase growth [40]. Whether PNSNP32 has some 
bearing on the stationary phase growth rate of isolates 
PANOT340 and PANOT738 in comparison with isolate 
PANOT106 requires further investigation, as this may 
impact upon survival of the bacteria in the hospital 
setting. PNSNP5 is within a CDS potentially encoding a 
methylated-DNA--protein-cysteine methyltransferase, 
which is involved in the repair of alkylated DNA (EC 
2.1.1.63). Sensitivity testing for alkylating agents of 
the outbreak isolates may be warranted in light of the 
PNSNP5 data.
The remaining eight SNPs present only in isolate 
PANOT738 are associated with non-synonymous 
changes in three different CDSs and five intergenic 
regions. The three SNPs in CDSs are PNSNP33 found 
within a putative class III pyridoxal phosphate-depend-
ent aminotransferase (PA0530), PNSNP27 in tadZ 
(PA4303), and PNSNP16 in a putative transcriptional 
regulator (PA2846). The CDS for tadZ is within the wide-
spread colonisation island (WCI) encoding tight adher-
ence pili. The genes of the WCI are essential for biofilm 
formation and colonisation [41], which are impor-
tant virulence factors in P. aeruginosa. The PNSNP27 
within tadZ may therefore influence the success of iso-
late PANOT738 in forming biofilms and colonising the 
host, medical devices, or even medical surfaces such 
as the persistently colonised sink. Isolate PANOT738 
also contains PNSNP16 that is within PA2846, which 
is one of several predicted transcriptional (PA1430) 
Table 3
Comparison of well-validated single nucleotide 
polymorphisms in the Pseudomonas aeruginosa 
Nottingham outbreak isolates
SNP ID
P. aeruginosa Nottingham outbreak isolates
PANOT101 PANOT106 PANOT340 PANOT738 PANOTK11
PNSNP1 G G G G A
PNSNP2 T T G G T
PNSNP3 C C C A C
PNSNP4 T T T T C
PNSNP5 G G T T G
PNSNP6 A A A A G
PNSNP7 A A A A T
PNSNP8 T T T T C
PNSNP9 A A A A G
PNSNP10 T G G G T
PNSNP11 A T A A A
PNSNP12 G G G G A
PNSNP13 C T C C C
PNSNP14 G G G G C
PNSNP15 T T T T A
PNSNP16 G G G T G
PNSNP17 C C C C T
PNSNP18 C C C A C
PNSNP19 C C T T C
PNSNP20 A A A A C
PNSNP21 C C C C G
PNSNP22 C C C A C
PNSNP23 A A G G A
PNSNP24 A A A A C
PNSNP25 T G G G T
PNSNP26 A C C C C
PNSNP27 G G G T G
PNSNP28 A A A A G
PNSNP29 T T T T C
PNSNP30 C C C C T
PNSNP31 G G G A G
PNSNP32 A A C C A
PNSNP33 A A A C A
PNSNP34 G G G G C
PNSNP35 C C C A C
PNSNP36 G G G G T
PNSNP37 T T T T G
ID: identity; SNP: single nucleotide polymorphism.
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and response regulators (PA0928, PA1458, PA2656, 
PA5364, PA5483) that contain SNPs in these outbreak 
isolates, suggesting that differences in regulation may 
play a role in the phenotypes observed.
Discussion
Here, we have shown that genome sequence data 
obtained with high-throughput sequencing technolo-
gies can provide novel insights into the epidemiology 
and biology of hospital isolates of P. aeruginosa. One 
isolate, PANOTK11, was determined to be an outlier and 
not part of the same outbreak lineage as the other four 
isolates. This is based on genomic level sequence dif-
ferences; previous typing with PFGE and RAPD placed 
all five of these isolates into a single lineage.
Amongst the related isolates, we have demonstrated 
that P. aeruginosa lineages from a hospital setting 
contain a sufficient number of SNPs to allow the con-
struction of an epidemiological narrative — an impor-
tant benchmarking exercise that lays the foundations 
for future investigations into the fine-grained genomic 
epidemiology of this troublesome pathogen.
Table 4
Non-synonymous single nucleotide polymorphisms in the genome sequence data of Pseudomonas aeruginosa isolates from 
the outbreak in Nottingham 
SNP IDa Isolate SNPb PAO1
c Position 
in PAO1d
PAO1 
locuse PAO1 CDS annotation
PAO1 amino 
acid
SNP amino 
acid
PNSNP2 (C) A 3512351 PA3130 Hypothetical protein V G
PNSNP4 (G) A 4128733 PA3687 Phosphoenolpyruvate carboxylase W R
PNSNP5 (A) C 4032021 PA3596 Putative methylated-DNA--protein-cysteine methyltransferase C F
PNSNP7 (A) T 4000131 PA3568 Putative acetyl-coa synthetase I F
PNSNP9 G A 827118 PA0758 Hypothetical protein I T
PNSNP10 G T 1014510 PA0928 Sensor/response regulator hybrid T P
PNSNP11 T A 1028593 PA0938 Hypothetical protein Q L
PNSNP12 A G 1558547 PA1430 Transcriptional regulator LasR G D
PNSNP13 T C 1588334 PA1458 Two-component sensor R C
PNSNP14 C G 1590208 PA1459 Chemotaxis-specific methylesterase G R
PNSNP15 A T 1635647 PA1505 Molybdenum cofactor biosynthesis protein A L Q
PNSNP16 (A) C 3201052 PA2846 Putative transcriptional regulator L I
PNSNP17 (A) G 3007141 PA2656 Putative two-component sensor L F
PNSNP19 (A) G 5692646 PA5053 ATP-dependent protease peptidase subunit G D
PNSNP23 (C) T 6031991 PA5364 Putative two-component response regulator N S
PNSNP25 G T 2093908 PA1919 Ribonucleoside-triphosphate reductase activating protein, NrdG T P
PNSNP26 A C 5060237 PA4519 Ornithine decarboxylase G C
PNSNP27 T G 4827417 PA4303 TadZ P Q
PNSNP29 T C 5173073 PA4615 Putative oxidoreductase E K
PNSNP32 (G) T 1719347 PA1580 Type II citrate synthase D A
PNSNP33 (G) T 589009 PA0530 Putative class III pyridoxal phosphate-dependent aminotransferase L R
PNSNP34 (G) C 6174644 PA5483 Two-component response regulator AlgB L V
PNSNP36 T G 2686727 PA2402 Peptide synthase S Stop
PNSNP37 G T 2686790 PA2402 Peptide synthase D A
CDS: protein coding sequence; ID: identity; SNP: single nucleotide polymorphism; Stop: termination codon.
a  SNP ID from Table 3.
b  SNP from one of the isolates as listed in Table 3. Reverse complementary bases, in parenthesis, have been entered where the PAO1 strand 
is negative relative to the data in Table 3.
c  Base at this SNP location within the PAO1 genome sequence.
d  Position of the SNP within the PAO1 genome sequence.
e  CDS locus identifier from the PAO1 genome sequence.
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In addition, genome sequencing has highlighted the 
existence of strain-specific gene clusters that might 
underpin the tenacious survival of these strains within 
our hospital over many years. Several SNPs which may 
confer phenotypic differences between the isolates 
have been identified and bear further investigation, 
particularly as some may play a role in survival of iso-
lates in the hospital. These include SNPs within PA1580 
that could influence stationary phase growth rate and 
impact on the survival of the bacteria in the hospital 
setting, within PA3596 that could influence the sensi-
tivity to alkylating agents, and within PA4303 that may 
be important for biofilm formation. 
This study illustrates the potential of the first gen-
eration of high-throughput sequencing platforms in 
the investigation of hospital outbreaks. Relentless 
improvements in cost and performance (particularly 
those delivered recently by bench top sequencing [42]) 
as well as data analysis software, are taking these 
technologies ever closer to the clinical microbiology 
laboratories. With a price tag now comparable to the 
cost of traditional molecular typing, bacterial genome 
sequencing is now poised to impact on clinical practice.
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